Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > RZLT Rezolute > Detailed Quotes

RZLT Rezolute

2.710
-0.110-3.90%
Trading Session 09/26 10:33 ET
High
2.775
Open
2.775
Turnover
1.49K
Low
2.710
Pre Close
2.820
Volume
548.00
Market Cap
105.23M
P/E(TTM)
Loss
52wk High
8.190
Shares
38.83M
P/E(Static)
Loss
52wk Low
2.060
Float Cap
75.08M
Bid/Ask %
0.00%
Historical High
21.110
Shs Float
27.70M
Volume Ratio
0.07
Historical Low
2.060
Dividend TTM
--
Div Yield TTM
--
P/B
0.70
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
2.30%
Avg Price
2.724
Lot Size
1
Float Cap
75.08M
Bid/Ask %
0.00%
Historical High
21.110
Shs Float
27.70M
Volume Ratio
0.07
Historical Low
2.060
Dividend TTM
--
P/B
0.70
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
2.30%
Avg Price
2.724
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its products include RZ358-Phase 2, an antibody for the ultra-orphan indication of congenital hyperinsulinism, AB101-Phase 1, a once-weekly injectable basal insulin, and RZ402, which targets diabetic macular edema. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Redwood City, CA.
CEO: Mr. Nevan C. Elam
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...